Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
J Clin Invest. 2022 Oct 17;132(20):e157917. doi: 10.1172/JCI157917.
Bone is a common site of metastasis in lung cancer, but the regulatory mechanism remains incompletely understood. Osteoclasts are known to play crucial roles in osteolytic bone metastasis by digesting bone matrix and indirectly enhancing tumor colonization. In this study, we found that IL receptor 20 subunit β (IL-20RB) mediated a direct tumoral response to osteoclasts. Tumoral expression of IL-20RB was associated with bone metastasis of lung cancer, and functionally, IL-20RB promoted metastatic growth of lung cancer cells in bone. Mechanistically, tumor cells induced osteoclasts to secrete the IL-20RB ligand IL-19, and IL-19 stimulated IL-20RB-expressing tumor cells to activate downstream JAK1/STAT3 signaling, leading to enhanced proliferation of tumor cells in bone. Importantly, blocking IL-20RB with a neutralizing antibody significantly suppressed bone metastasis of lung cancer. Overall, our data revealed a direct protumor role of osteoclastic niche in bone metastasis and supported IL-20RB-targeting approaches for metastasis treatment.
骨是肺癌转移的常见部位,但调节机制仍不完全清楚。破骨细胞通过消化骨基质间接促进肿瘤定植,在溶骨性骨转移中起着至关重要的作用。在这项研究中,我们发现白细胞介素受体 20 亚基β(IL-20RB)介导了破骨细胞对肿瘤的直接反应。肿瘤中 IL-20RB 的表达与肺癌的骨转移有关,并且在功能上,IL-20RB 促进了肺癌细胞在骨中的转移生长。在机制上,肿瘤细胞诱导破骨细胞分泌 IL-20RB 配体 IL-19,IL-19 刺激表达 IL-20RB 的肿瘤细胞激活下游 JAK1/STAT3 信号通路,导致骨内肿瘤细胞的增殖增强。重要的是,用中和抗体阻断 IL-20RB 显著抑制了肺癌的骨转移。总的来说,我们的数据揭示了破骨细胞龛在骨转移中的直接促肿瘤作用,并支持针对 IL-20RB 的治疗方法来治疗转移。